摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,4-di(tetradecyloxy)phenylamine | 156450-77-0

中文名称
——
中文别名
——
英文名称
3,4-di(tetradecyloxy)phenylamine
英文别名
3,4-bis(tetradecyloxy)aniline;3,4-di(tetradecyloxy)aniline;3,4-bis(tetradecyloxy)benzenamine;3,4-di(tetradecoxy)aniline
3,4-di(tetradecyloxy)phenylamine化学式
CAS
156450-77-0
化学式
C34H63NO2
mdl
——
分子量
517.88
InChiKey
GSUZAOSJKWWVIQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    14.5
  • 重原子数:
    37
  • 可旋转键数:
    28
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.82
  • 拓扑面积:
    44.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Mesomorphic Dithiooxamide Complexes of Platinum(II)
    摘要:
    Complexation of non-mesomorphic dithiooxamide ligands to Pt(II) leads to square planar complexes which exhibit mesomorphic properties. The synthesis of these complexes was accomplished in three steps: the formation of bisamides, starting from conveniently substituted anilines, their conversion into dithiooxamides and the reaction of these sulfur derivatives with [PtCl2(dmso)(2)]. Four, eight and twelve-chained complexes were obtained and their behaviour as potentially mesomorphic material was studied. The eight-chained complexes 21 (n = 12-16) and the twelve-chained complexes 22 (n = 8,11,13) exhibit columnar mesophases which have been characterised by optical microscopy, X-ray scattering and related miscibility studies.
    DOI:
    10.1080/10587250008024795
  • 作为产物:
    描述:
    4-硝基儿茶酚 在 tin(ll) chloride 作用下, 生成 3,4-di(tetradecyloxy)phenylamine
    参考文献:
    名称:
    Mesomorphic Dithiooxamide Complexes of Platinum(II)
    摘要:
    Complexation of non-mesomorphic dithiooxamide ligands to Pt(II) leads to square planar complexes which exhibit mesomorphic properties. The synthesis of these complexes was accomplished in three steps: the formation of bisamides, starting from conveniently substituted anilines, their conversion into dithiooxamides and the reaction of these sulfur derivatives with [PtCl2(dmso)(2)]. Four, eight and twelve-chained complexes were obtained and their behaviour as potentially mesomorphic material was studied. The eight-chained complexes 21 (n = 12-16) and the twelve-chained complexes 22 (n = 8,11,13) exhibit columnar mesophases which have been characterised by optical microscopy, X-ray scattering and related miscibility studies.
    DOI:
    10.1080/10587250008024795
点击查看最新优质反应信息

文献信息

  • N-substituted anilines, inhibitors of phospholipases A.sub.2
    申请人:Hoffmann-La Roche Inc.
    公开号:US05324747A1
    公开(公告)日:1994-06-28
    Compounds of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, n, m, o, p and q are as hereinafter set forth, and, when R.sub.2 is hydrogen, pharmaceutically acceptable salts thereof with bases, are described. The compounds of formula 1 are potent inhibitors of phospholipases A.sub.2 (PLA.sub.2 's) and are therefore useful in the treatment of inflammatory diseases, such as psosiasis, inflammatory bowel disease, asthma, allergy, arthritis, dermatitis, gout, pulmonary disease, myocardial ischemia/reperfusion, and trauma induced inflammation, such as spinal cord injury.
    本文描述了具有以下结构式的化合物##STR1## 其中R.sub.1、R.sub.2、R.sub.3、R.sub.4、R.sub.5、R.sub.6、R.sub.7、R.sub.8、n、m、o、p和q如下所述,以及当R.sub.2为氢时,它们与碱形成的药用可接受的盐。公式1的化合物是磷脂酶A.sub.2(PLA.sub.2's)的有效抑制剂,因此在治疗炎症性疾病方面非常有用,例如屑病、炎症性肠病、哮喘、过敏、关节炎、皮炎、痛风、肺部疾病、心肌缺血/再灌注以及创伤诱导的炎症,如脊髓损伤。
  • Liquid crystalline properties of bis(salicylaldiminato)copper(II) complexes: the first columnar discotics derived from salicylaldimine Schiff bases
    作者:Chung K. Lai、Chung-hsiung Chang、Chun-hsien Tsai
    DOI:10.1039/a707091h
    日期:——
    The synthesis and mesomorphic properties of a homologous series ofN-(2-hydroxy-4-n-alkoxybenzylidene)-3′,4′-di-n-alkoxylanilines and their copper(ii) complexes bis[(N-3′,4′-dialkoxyphenyl)-4-n-alkoxylsalicylaldiminato]copper(ii) are reported. The disc-like copper complexes exhibited columnar hexagonal disordered mesophases, which were characterized by DSC analysis and optical polarized microscopy. The structure of the mesophases was confirmed by X-ray powder diffraction (XRD). The mesomorphic properties for these copper complexes were compared with other similar metallomesogenic bis(salicylaldiminato)copper(ii) complexes in terms of molecular structural differences.
    报道了一组N-(2-羟基-4-正烷氧基苯亚甲基)-3′,4′-二-正烷氧基苯胺及其(II)配合物双[(N-3′,4′-二烷氧基苯基)-4-正烷氧基水杨醛亚胺](II)的合成与液晶性质。盘状配合物表现出无序的柱状六方相,通过差示扫描量热分析和偏光显微镜进行了表征。通过X射线粉末衍射(XRD)确定了其相结构。与其他类似的属配位液晶双(水杨醛亚胺)(II)配合物相比,这些配合物的液晶性质与其分子结构差异有关。
  • New star-shaped triarylamines: synthesis, mesomorphic behavior, and photophysical properties
    作者:Yueh-Ju Wang、Hwo-Shuenn Sheu、Chung K. Lai
    DOI:10.1016/j.tet.2006.11.058
    日期:2007.2
    mesomorphic properties were also investigated. Compounds 1–4 and 5,6 were prepared from p,p′,p″-triformyltriphenylamine and p,p′-diformyltriphenylamine with appropriate alkoxyphenylamines. The phase behavior of these mesogenic compounds was characterized and studied by differential scanning calorimetry, polarized optical microscopy, and powder XRD diffraction. Compounds 1–3 exhibited columnar mesophase
    共有18个化合物1 - 6从三苯胺作为核心组衍生的制备和表征,以及它们的介晶性能进行了研究。化合物1 - 4和5,6是从制备p,p ',p “和-triformyltriphenylamine p,p具有适当alkoxyphenylamines'-diformyltriphenylamine。这些介晶化合物的相行为已通过差示扫描量热法,偏振光学显微镜和粉末XRD衍射进行了表征和研究。化合物1 - 3展出柱状相,然而,化合物4 - 6是nonmesogenic。化合物中观察到的中间相1 - 3被认为是侧依赖性的。附有一个,两个或三个侧链的化合物1a,2a和3a表现为层状柱状(Col L)相,具有四个或六个侧链的化合物2b和3b形成六方柱状(Col h)相。中间相(层状或柱状中间相)的形成可能是由–CH 2之间形成的氢键引起的。NH组。循环伏安法测定的氧化过程显示出两个氧化还原波,一个在220-255
  • Intermediates for the production of N-substituted anilines, inhibitors
    申请人:Hoffmann-La Roche Inc.
    公开号:US05446189A1
    公开(公告)日:1995-08-29
    Compounds of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, n, m, o, p, and q are as hereinafter set forth, and, when R.sub.2 is hydrogen, pharmaceutically acceptable salts thereof with bases, are described. The compounds of formula 1 are potent inhibitors of phospholipases A.sub.2 (PLA.sub.2 's) and are therefore useful in the treatment of inflammatory diseases, such as psosiasis, inflammatory bowel disease, asthma, allergy, arthritis, dermatitis, gout, pulmonary disease, myocardial ischemia/reperfusion, and trauma induced inflammation, such as spinal cord injury.
    本发明涉及化合物的配方##STR1##其中R.sub.1、R.sub.2、R.sub.3、R.sub.4、R.sub.5、R.sub.6、R.sub.7、R.sub.8、n、m、o、p和q如下所述,当R.sub.2为氢时,其与碱的药物可接受的盐也被描述。式1的化合物是磷脂酶A.sub.2(PLA.sub.2's)的有效抑制剂,因此在治疗炎症性疾病,如牛皮癣、炎症性肠病、哮喘、过敏、关节炎、皮炎、痛风、肺部疾病、心肌缺血/再灌注以及创伤引起的炎症,如脊髓损伤中有用。
  • The enhanced π–π interactions in metallomesogens
    作者:Ta-Ming Liu、Kuan-Ting Lin、Fu-Joun Li、Gene-Hsiang Lee、Ming-Chou Chen、Chung K. Lai
    DOI:10.1016/j.tet.2015.09.006
    日期:2015.11
    Two new series of mesogenic palladium complexes 1a-b derived from salicylaldimines containing phenyl or naphenyl moiety were prepared, characterized and their mesomorphic properties investigated. Two single crystallographic structures of mesogenic 1a (n=4) and nonmesogenic 1b (n=3) were determined by X-ray analysis; both crystals crystallize in a triclinic space group P1. The geometry at both palladium atoms was nearly square planar. All Schiff bases 2a-b and palladium complexes lab exhibited mesomorphic properties. However, the formation of mesophases was sensitive to terminal naphthalyl and phenyl group. Compounds 2a formed N or/and SmC phases and compounds 2b exhibited N or/and SmC phases. In contrast, palladium complexes 1a formed N or N/SmC phases and complexes 1b exhibited N, N or/and SmC phases. Compounds 1b have a higher clearing temperature than those of 1a by a Delta T-cl=35.4-14.8 degrees C. An improved mesomorphic behavior observed in compounds 1b was attributed to the H-bonds and pi-pi interaction. (C) 2015 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯